Angara
founders:
Ku-Lung Hsu, Ph.D.
Angara has optioned a platform technology comprising a library of powerful probes for activity-based protein profiling, a unique means to measure the functional state of a large number of enzymes in native biological systems that allow for identification of new drug targets and determination of inhibitor selectivity.